GVHD
-
-
Acute
-
Prevention
-
VICCCTT25042
Phase 2 Study of Ruxolitinib-Based Primary Treatment for Acute GVHD
-
AML Post-SCT in CR1
-
-
Chronic
-
1st Line
-
No Current Trials
-
-
2nd Line and Above
-
-